News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orgenesis to Sponsor and Present at ESGCT 20th Anniversary Congress



10/24/2012 9:20:12 AM

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce its participation and sponsorship at the European Society of Gene & Cell Therapy (“ESGCT”) 20th Anniversary Congress, to be held October 26-29, 2012 in Versailles, France.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES